MarketPeel
Insider Trading Intelligence
Pricing
…
CS

Christopher Paul Simms

FDMT
SEE REMARKS · 4D MOLECULAR THERAPEUTICS, INC. · CIK 0001877012
FILING MIX · LIFETIME100%/0%
BUYS
1
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Mar 2026
HOLDINGS NOW
219,000
AVG SELL PX
—
TRADE KIND
SHOWING 1 / 1
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Christopher Paul Simms. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 1 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
219,000——219,000Mar 25, 2026Mar 27, 2026 ↗
Other insiders · FDMT
Loading peer insiders…
About this filer
CIK 0001877012
ROLE
See Remarks
PRIMARY
FDMT
COMPANIES
1
ACTIVE SINCE
Mar 2026
MARKETPEEL · /INSIDER/0001877012DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback